Leaderboards/Respiratory viral infections research

Respiratory viral infections research

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Bo Meng
University of Cambridge
2
Sonia Ares‐Gómez
Instituto de Salud Carlos III
3
Jobie Budd
London Centre for Nanotechnology
4
Stephanie Goya
University of Washington Medical Center
5
Jennifer Loske
Humboldt-Universität zu Berlin
6
Calvin J. Gordon
University of Alberta
7
Salma Sheikh‐Mohamed
University of Toronto
8
Corinna Ernst
Luxembourg Institute of Health
9
Gonzalo Pérez Marc
Johns Hopkins University
10
Lisa Staadegaard
Netherlands Institute for Health Services Research

Papers

1
Publication in The Lancet Infectious Diseases (2024) [237 citations, W4396520764]
The Lancet Infectious Diseases|2024
237 cit.
2
Publication in Eurosurveillance (2024) [135 citations, W4391258475]
Eurosurveillance|2024
135 cit.
3
Standardized Phylogenetic Classification of Human Respiratory Syncytial Virus Below the Subgroup Level
Emerging infectious diseases|2024
68 cit.
4
Pharmacological Improvement of Cystic Fibrosis Transmembrane Conductance Regulator Function Rescues Airway Epithelial Homeostasis and Host Defense in Children with Cystic Fibrosis
American Journal of Respiratory and Critical Care Medicine|2024
48 cit.
5
Publication in Pediatric Allergy and Immunology (2024) [19 citations, W4396613401]
Pediatric Allergy and Immunology|2024
19 cit.
6
Publication in Eurosurveillance (2024) [12 citations, W4391475068]
Eurosurveillance|2024
12 cit.
7
Mechanism and spectrum of inhibition of a 4′-cyano modified nucleotide analog against diverse RNA polymerases of prototypic respiratory RNA viruses
Journal of Biological Chemistry|2024
12 cit.
8
Genomic Epidemiology and Evolution of Rhinovirus in Western Washington State, 2021–2022
The Journal of Infectious Diseases|2024
10 cit.
9
Phylodynamics of human metapneumovirus and evidence for a duplication-deletion model in G gene variant evolution
Journal of Clinical Virology|2025
8 cit.
10
Hypoxia drives HIF2-dependent reversible macrophage cell cycle entry
Cell Reports|2024
5 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Nader Yatim
Institut Pasteur
2
Lei Liu
Hunan Agricultural University
3
Leif Erik Sander
Humboldt-Universität zu Berlin
4
Veronica Hulstrøm
GlaxoSmithKline (Belgium)
5
Mingkun Li
Chinese Academy of Sciences
6
Neil P. King
University of Washington
7
Desiree Mustaquim
Centers for Disease Control and Prevention
8
Alexander V. Misharin
Northwestern University
9
Ziyou Ren
Northwestern University
10
Eva Molero
Universitat de València

Papers

1
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
New England Journal of Medicine|2023
748 cit.
2
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial
The Journal of Infectious Diseases|2022
118 cit.
3
Estimation of the Number of Respiratory Syncytial Virus–Associated Hospitalizations in Adults in the European Union
The Journal of Infectious Diseases|2023
103 cit.
4
Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis
The Journal of Infectious Diseases|2022
96 cit.
5
Burden of Respiratory Syncytial Virus in the European Union: estimation of RSV-associated hospitalizations in children under 5 years
The Journal of Infectious Diseases|2023
96 cit.
6
Immune evasion and ACE2 binding affinity contribute to SARS-CoV-2 evolution
Nature Ecology & Evolution|2023
74 cit.
7
Genomic Perspectives on the Emerging SARS-CoV-2 Omicron Variant
Genomics Proteomics & Bioinformatics|2022
72 cit.
8
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens
Cell Reports Medicine|2022
51 cit.
9
Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children
The Journal of Infectious Diseases|2022
49 cit.
10
Economic Burden and Health-Related Quality of Life of Respiratory Syncytial Virus and Influenza Infection in European Community-Dwelling Older Adults
The Journal of Infectious Diseases|2022
43 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Yoshihiro Kawaoka
University of Wisconsin–Madison
2
Peter Palese
Icahn School of Medicine at Mount Sinai
3
Robert G. Webster
St. Jude Children's Research Hospital
4
Albert D. M. E. Osterhaus
University of Veterinary Medicine Hannover, Foundation
5
Kwok‐Yung Yuen
University of Hong Kong - Shenzhen Hospital
6
Brian R. Murphy
National Institute of Allergy and Infectious Diseases
7
Barney S. Graham
National Institutes of Health
8
Cynthia G. Whitney
The Task Force for Global Health
9
Larry J. Anderson
Children's Healthcare of Atlanta
10
Ron A. M. Fouchier
Erasmus MC

Papers

1
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
Clinical Infectious Diseases|2007
6.2k cit.
2
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
New England Journal of Medicine|2012
6k cit.
3
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
American Journal of Respiratory and Critical Care Medicine|2019
3.6k cit.
4
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Emerging Microbes & Infections|2020
3.3k cit.
5
Coronavirus as a possible cause of severe acute respiratory syndrome
The Lancet|2003
3k cit.
6
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
The Lancet|2003
2.5k cit.
7
Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
New England Journal of Medicine|2003
2.2k cit.
8
Evolution and ecology of influenza A viruses.
Microbiological Reviews|1992
2.2k cit.
9
A newly discovered human pneumovirus isolated from young children with respiratory tract disease
Nature Medicine|2001
2.2k cit.
10
Mapping the Antigenic and Genetic Evolution of Influenza Virus
Science|2004
2k cit.

Reagents for Respiratory viral infections research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Sigma-Aldrich

Anti-CDHR3 antibody produced in rabbit

#HPA011218
View Evidence →
BD Biosciences

CD15s (Sialyl Lewis x)

#551344
View Evidence →

⭐ Top Rated

Best all-around

Thermo Fisher ScientificEvidence 66

EPCAM Recombinant Rabbit Monoclonal Antibody

Cited in 6 papers
#RAB02492
View Evidence →
Thermo Fisher ScientificEvidence 77

CD326 (EpCAM) Monoclonal Antibody (VU-1D9), Alexa Fluor Plus 555

Cited in 6 papers
#754-1062-94
View Evidence →
Thermo Fisher ScientificEvidence 77

CD326 (EpCAM) Monoclonal Antibody (VU-1D9), Alexa Fluor Plus 750

Cited in 6 papers
#757-1062-94
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 63

AFP (F2E9D) Rabbit Monoclonal Antibody

Cited in 10 papers
#35190$178,415
View Evidence →
Cell Signaling TechnologyEvidence 60

RanBP1 Antibody

Cited in 7 papers
#8780$317
View Evidence →
Cell Signaling TechnologyEvidence 63

NME1/NDKA (D14H1) Rabbit Monoclonal Antibody

Cited in 6 papers
#5353$161,351
View Evidence →